![U.S. Direct-to-Consumer Genetic Testing Market](https://www.skyquestt.com/assets/frontend/images/upcoming_reports_cover_image.jpg)
Report ID: UCMIR35D2194
Report ID:
UCMIR35D2194 |
Region:
Regional |
Published Date: Upcoming |
Pages:
165
| Tables: 55 | Figures: 60
The U.S. Direct-to-Consumer Genetic Testing Market exhibited significant growth, reaching a valuation of more than USD 1.5 billion in 2022. The market is projected to maintain this upward trajectory with an estimated compound annual growth rate (CAGR) of over 11% from 2023 to 2032. This surge in demand can be attributed to increasing consumer awareness about the benefits of genetic testing, as well as advancements in technology and genetic research. As more individuals seek personalized health insights and ancestry information, the direct-to-consumer genetic testing sector is likely to witness sustained expansion in the coming years, revolutionizing the way people engage with their genetic information.
This report is being written to illustrate the market opportunity by region and by segments, indicating opportunity areas for the vendors to tap upon. To estimate the opportunity, it was very important to understand the current market scenario and the way it will grow in future.
Production and consumption patterns are being carefully compared to forecast the market. Other factors considered to forecast the market are the growth of the adjacent market, revenue growth of the key market vendors, scenario-based analysis, and market segment growth.
The market size was determined by estimating the market through a top-down and bottom-up approach, which was further validated with industry interviews. Considering the nature of the market we derived the Health Care Services by segment aggregation, the contribution of the Health Care Services in Health Care Equipment & Services and vendor share.
To determine the growth of the market factors such as drivers, trends, restraints, and opportunities were identified, and the impact of these factors was analyzed to determine the market growth. To understand the market growth in detail, we have analyzed the year-on-year growth of the market. Also, historic growth rates were compared to determine growth patterns.
Our industry expert will work with you to provide you with customized data in a short amount of time.
REQUEST FREE CUSTOMIZATIONThe market for U.S. Direct-to-Consumer Genetic Testing was estimated to be valued at US$ XX Mn in 2021.
The U.S. Direct-to-Consumer Genetic Testing Market is estimated to grow at a CAGR of XX% by 2028.
The U.S. Direct-to-Consumer Genetic Testing Market is segmented on the basis of Test, Technology, Distribution Channel, State.
Based on region, the U.S. Direct-to-Consumer Genetic Testing Market is segmented into North America, Europe, Asia Pacific, Middle East & Africa and Latin America.
The key players operating in the U.S. Direct-to-Consumer Genetic Testing Market are , Ancestry , Easy DNA , 23andMe Inc. , HomeDNA , Counsyl , Living DNA Ltd. , Pathway genomics , Others .
Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.
Report ID: UCMIR35D2194